title: Role of Positron Emission Tomography with Fludeoxyglucose F 18 in Personalization of Therapy in Patients with Lymphoma.
abstract: The widespread availability of functional imaging in clinical practice has revolutionized the care (staging, response assessment, surveillance) of patients with lymphoma. Using positron emission tomography/computed tomography (PET/CT) with fludeoxyglucose F 18 (FDG), the potential exists for prognostic risk stratification and therapeutic adjustment. This review focuses on personalization of therapy using these 2 modalities in 2 lymphoma subtypes: diffuse large B-cell lymphoma and Hodgkin lymphoma.
authors.affiliation: John Theurer Cancer Center at Hackensack University Medical Center, 92 Second Street, Hackensack, NJ 07601, USA.
authors.forename: Anthony R
authors.initials: AR
authors.lastname: Mato
authors.forename: Andre
authors.initials: A
authors.lastname: Goy